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Abstract Metzincin metalloproteases have major roles in intercellular communication by
modulating the function of membrane proteins. One of the proteases is the a-disintegrin-and-
metalloprotease 10 (ADAM10) which acts as alpha-secretase of the Alzheimer’s disease amyloid
precursor protein. ADAM10 is also required for neuronal network functions in murine brain, but
neuronal ADAM10 substrates are only partly known. With a proteomic analysis of Adam10-deficient
neurons we identified 91, mostly novel ADAM10 substrate candidates, making ADAM10 a major
protease for membrane proteins in the nervous system. Several novel substrates, including the
neuronal cell adhesion protein NrCAM, are involved in brain development. Indeed, we detected
mistargeted axons in the olfactory bulb of conditional ADAM10-/- mice, which correlate with
reduced cleavage of NrCAM, NCAM and other ADAM10 substrates. In summary, the novel
ADAM10 substrates provide a molecular basis for neuronal network dysfunctions in conditional
ADAM10-/- mice and demonstrate a fundamental function of ADAM10 in the brain.
DOI: 10.7554/eLife.12748.001
Kuhn et al. eLife 2016;5:e12748. DOI: 10.7554/eLife.12748 1 of 29
RESEARCH ARTICLE
Introduction
Proteolysis of cell surface membrane proteins is a basic cellular mechanism that controls intercellular
communication and the interaction of cells with their extracellular environment. Proteolysis typically
occurs close to the luminal or extracellular side of the membrane and results in release of the mem-
brane protein’s ectodomain. This process, referred to as ectodomain shedding, is a mechanism that
shapes the cell surface by controlling the ectodomain length of cell surface membrane proteins thus
modulating their function (Weber and Saftig, 2012).
Membrane-bound metalloproteases of the metzincin family have a key role in catalyzing ectodo-
main shedding of membrane proteins, in particular members of the ‘a disintegrin and metallopro-
tease’ (ADAM) subfamily (Weber and Saftig, 2012). One of them is ADAM10, which is a
ubiquitously expressed type I membrane protein whose active site is located within its ectodomain,
well positioned to shed the ectodomains of its substrates (Weber and Saftig, 2012). A key substrate
for ADAM10 is the Notch receptor, which requires ADAM10-mediated shedding for its signaling
during differentiation and development (Hartmann et al., 2002; Qi et al., 1999). Consequently,
constitutive ADAM10-deficient mice die at embryonic day 9.5 most likely due to a loss of Notch sig-
naling (Hartmann et al., 2002). Another major substrate of ADAM10 is the amyloid precursor pro-
tein (APP) for which ADAM10 acts as the constitutive alpha-secretase (Postina et al., 2004;
Lammich et al., 1999; Kuhn et al., 2010; Jorissen et al., 2010) and thus possesses the ability to
prevent the generation of the pathogenic Ab peptide in Alzheimer’s disease (AD) (Lammich et al.,
1999; Kuhn et al., 2010). This makes ADAM10 a major drug target for AD (Postina et al., 2004),
and an activator of ADAM10 expression has been tested in a clinical trial for AD (Endres et al.,
2014). Whether such a therapeutic approach is safe, remains to be seen, in particular because rela-
tively little is known about ADAM10 substrates in brain.
Besides Notch and APP, additional ADAM10 substrates, such as E-cadherin and CX3CL1, have
been identified in different organs and tissues (Hundhausen et al., 2003). Given the embryonically
lethal phenotype of constitutive ADAM10-deficient mice, little is known about ADAM10 substrates
eLife digest Several neurodegenerative disorders, including Alzheimer’s disease, arise when
protein-cutting enzymes process proteins in the wrong way. The resulting protein fragments can
accumulate in nerve cells and cause them to die, leading to symptoms such as memory loss. In the
case of Alzheimer’s disease the toxic protein fragment – called amyloid beta – can be produced
when one enzyme cuts the amyloid precursor protein. However, the amyloid beta fragment is not
made when a different enzyme called ADAM10 cuts the amyloid precursor protein first.
There has been a lot of interest in finding drugs that activate ADAM10 to treat Alzheimer’s
disease. However, ADAM10 also cuts other proteins on the surface of cells and it is important to
know about these proteins if ADAM10 is going to be successfully targeted by a drug.
To tackle this issue, Kuhn et al. have now searched for new proteins (or ‘substrates’) that are cut
by ADAM10 in mouse nerve cells. The experiments identified proteins that were cut in normal nerve
cells, but remained unprocessed in cells where the gene for ADAM10 had been deleted. This search
uncovered almost 100 new substrates of ADAM10 that were then validated using biochemical
techniques.
Among these substrates were many proteins that are normally anchored into the membranes of
nerve cells and involved in guiding and positioning these cells in the brain so that they can connect
and communicate with each other. Kuhn et al. then deleted the gene for ADAM10 only in the
frontmost part of the mouse brain. This led to the nerve cells forming abnormal networks in the
regions of the brain that process smells and emotions. Overall the experiments proved that
ADAM10 is important not only for the prevention of Alzheimer’s disease, but also for the normal
development of the brain. Future studies could now explore how stimulating ADAM10 affects the
levels of its substrates. Also, a better understanding of the substrates of ADAM10 may be useful
both to predict side effects of drugs that activate ADAM10 and to monitor patients who are
responding well to these drugs.
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in the central nervous system (Hartmann et al., 2002). A few ADAM10 substrates have been identi-
fied in the brain. Some of them have neuronal and synaptic functions, such as APP (Ring et al.,
2007; Weyer et al., 2011; 2014), Neuroligin-1 (Blundell et al., 2010; Kim et al., 2008) or N-Cad-
herin, which is in line with the phenotypes reported for conditional ADAM10-/- mice lacking
ADAM10 expression in most neurons (Jorissen et al., 2010; Gibb et al., 2010; Prox et al., 2013).
While these mice circumvent ADAM10 dependent embryonic lethality, they show epileptic seizures,
learning deficits and an altered morphology of postsynaptic structures in the brain and die postna-
tally. This demonstrates that ADAM10 is essential for synaptic and neuronal network functions in the
mouse brain (Jorissen et al., 2010; Prox et al., 2013).
Yet, the known ADAM10 substrates only partly explain these phenotypes and more ADAM10
substrates are expected to exist in brain. Their identification will allow a better mechanistic under-
standing of ADAM10 function in brain. Moreover, new ADAM10 substrates may be useful as bio-
markers to evaluate how a patient responds to an ADAM10-modulating drug, for example in clinical
trials for AD.
To systematically identify neuronal ADAM10 substrates, we used the quantitative proteomic
‘secretome protein identification with click sugars’ (SPECS) method, which has already been success-
fully applied to the identification of substrates for the membrane proteases BACE1 and SPPL3
(Kuhn et al., 2012; 2015). SPECS allows specific enrichment of cell-derived glycoproteins which oth-
erwise would escape detection by mass spectrometry due to their low abundance. Using high-reso-
lution mass spectrometry and label-free quantification we systematically analyzed both the levels of
membrane proteins in the neuronal membrane as well as their shed ectodomains in the secretome
of primary, murine neurons, either expressing or lacking ADAM10. We identified 91, mostly novel
ADAM10 substrate candidates.
Selected substrates, including NRCAM, LDLR, MT4MMP and CDH6 were validated by quantita-
tive immunoblots in neurons and in mouse brain and point to a central function of ADAM10 in syn-
apse formation and axon targeting. In line with this we detected an axon targeting defect in the
olfactory bulb of conditional ADAM10-/- mice, similar to what has been observed in mice deficient
in the novel ADAM10 substrate NRCAM.
Results
Identification of neuronal ADAM10 substrate candidates
To identify novel ADAM10 substrates we quantitatively compared the secretome of neurons with
and without ADAM10 activity following the rationale that a lack in ADAM10 activity would reduce or
almost abolish ectodomain shedding of a defined fraction of single span membrane proteins with
other membrane proteins and soluble proteins being unaffected. To this aim, we isolated and cul-
tured primary neurons from E15/E16 brains of a conditional Adam10 knockout mouse model (Ad10
fl/fl) allowing an Adam10 specific knockout upon iCre expression (Gibb et al., 2010). After two days
in vitro (DIV) neurons were either transduced with an empty control lentivirus or a lentivirus that
coded for iCre (Figure 1A). Two days later, neurons were incubated for another two days with the
chemically modified sugar ManNAz, which is metabolized and incorporated as sialic acid into the
glycan moieties of newly synthesized, cellular glycoproteins. Staining for beta III tubulin suggests
that knockout of ADAM10 did not alter neuronal differentiation of primary neurons in vitro
(Figure 1A). Media of both experimental conditions (conditioned for 48 hr) were processed with the
SPECS method to selectively enrich the endogenous, cellular glycoproteins in the medium. Consider-
ing at least two unique peptides per protein and detection of the protein (protein group) in at least
4 out of 5 biological replicates the mass spectrometric analysis identified 313 proteins annotated as
glycoproteins. For every glycoprotein we mapped all identified peptides to its extracellular, trans-
membrane and cytoplasmic domains, using the QARIP webserver (Ivankov et al., 2013). The major-
ity of peptides matched to the extracellular domain, but not to the transmembrane or cytoplasmic
domains (data not shown), which demonstrates that we had detected the proteolytically released
ectodomain and not the full-length membrane proteins in the neuronal secretome.
We classified these glycoproteins according to their topology (Figure 1B). These comprised 113
secreted proteins and 200 membrane proteins of which 108 had type I orientation (Figure 1B). Pro-
teins with other membrane orientations or with a GPI-anchor were also detected (Figure 1B) which
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Figure 1. Identification of candidate ADAM10 substrates in conditional ADAM10-/- neurons. (A) Workflow for the identification of ADAM10 substrates
in the secretome of primary cortical neurons comprising plating of neurons, lentiviral transduction, metabolic glycan labeling, purification and protein
Figure 1 continued on next page
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is similar to the data in our seminal SPECS study that identified BACE1 substrates in the neuronal
secretome (Kuhn et al., 2012).
Label-free-quantification of our mass spectrometric analysis revealed that the levels of 91 glyco-
proteins were significantly reduced in the secretome upon Adam10 deletion considering a p-value
cut off of 0.05 based on 5 biological replicates (Figure 1C, Supplementary file 1 – A10 knockout
quantified secretome data set). When applying false-discovery rate (FDR)-based multiple hypothesis
testing according the method of Benjamini and Hochberg considering an FDR = 0.1 and all identi-
fied glycoproteins as hypotheses, 46 membrane proteins remain significantly reduced (Figure 1C
and Table 1).
Surprisingly, not a single glycoprotein was significantly increased in the secretome upon Adam10
deletion. Topological classification of the 91 glycoproteins (p<0.05) with reduced levels in the
Adam10-/- neuronal secretome revealed a strong enrichment of type-I membrane proteins
(Figure 1B). Among the 91 significantly changed glycoproteins we identified 78 membrane proteins
comprising 57 type-I, 6 GPI-anchored, 1 type-I/GPI-anchored, 5 polytopic and 9 type-II membrane
proteins which we considered as potential ADAM10 substrate candidates due to their membrane
localization (Supplementary file 1 – A10 knockout quantified secretome dataset).
Among the significantly reduced proteins upon Adam10 deletion, type-I membrane proteins
were enriched to 70% compared to the total secretome that contains only 39% type-I membrane
protein (Figure 1E). This enrichment of membrane proteins with a type-I orientation was even more
pronounced when we assigned the topology to the 42 most significantly reduced glycoproteins
upon Adam10 deletion in the secretome of which 90% possess a type-I orientation (Table 1), which
is in line with the observation that most previously identified ADAM10 substrates also have a type I
orientation (Weber and Saftig, 2012).
Among all identified ADAM10 substrate candidates we found previously described ADAM10 sub-
strates like Neuroligin-1 (NLGN1), fractalkine (CX3CL1) or the amyloid precursor protein (APP)
(Figure 1C, yellow ring with green cross) which validated our experimental approach
(Lammich et al., 1999; Kuhn et al., 2010; Hundhausen et al., 2003; Suzuki et al., 2012;
Reiss et al., 2005; Colombo et al., 2013). The formerly known ADAM10 substrate N-Cadherin
(CDH2) was borderline significant due to one outlier. Our SPECS-based substrate identification was
characterized by high sensitivity as even small reductions in total shedding were detected in
ADAM10-/- cells. For example, in neurons APP is mostly shed by the aspartyl protease BACE1 and
only to a low extent by ADAM10 (Colombo et al., 2013). Yet a 20% reduction in APP shedding
upon Adam10 deletion was clearly detected in our SPECS analysis. Interestingly, some substrates,
such as Neuroligin-1 are ‘exclusive’ ADAM10 substrates, as their shedding was nearly completely
abolished upon ADAM10 deletion. However, for other substrates including APP and CHL1, shedding
was only partly reduced in ADAM10-/- neurons, indicating that they are not only substrates for
ADAM10, but also for other proteases.
The list of identified ADAM10 substrate candidates comprises entire receptor families involved in
synapse function and formation and axon targeting (Figure 1F). This became apparent for example
for the receptor tyrosine phosphatase (Ptpr), the Neuroligin (NLGN), the Neurexin (NRXN) and the
SLIT and NTRK (Slitrk) families, which are involved in synapse function, and the L1 adhesion molecule
family, which is involved in axon targeting. In case of the receptor tyrosine phosphatase family
Figure 1 continued
identification and quantification via mass spectrometry. Staining of primary cortical neurons for the neuron specific marker beta III tubulin and the
nuclear stain DAPI followed by quantification of beta III tubulin staining supports that neuronal differentiation was unaffected by deletion of ADAM10.
(B) Topology of all glycoproteins in the secretome. (C) Volcano plot of the quantitative comparison between the secretomes of wild type (wt) and
Adam10 knockout neurons of all in at least 4 out of 5 experiments identified glycoproteins in the secretome of Adam10-/- and wt neurons. The p-value
is depicted as negative decadic logarithm while the fold-change (Adam10-/-/wt) is depicted as log2 value. Significantly changed protein: p0,05 (-
log101,3). Substrates that are significantly reduced are marked red. Proteins which were validated with immunoblot have a yellow ring. Proteins which
have been formerly described in literature as ADAM10 substrates are marked with a green cross. Hits whose p-values survived correction for multiple
hypothesis testing yielded a p-value of at least 0.00135 as new significance niveau. (D) Topology of all significantly changed proteins in the secretome
between Adam10-/- and wt neurons. (E) Percentage of all membrane proteins with type-I topology in the total secretome and among the significantly
changed proteins upon Adam10 knockout. (F) Remaining shedding after Adam10 deletion in percent for members of selected protein families like the
Neurexin (NRXN), Neuroligin (NLGN), receptor tyrosine phosphatase (PTPR), Slit and receptor tyrosine kinase domain (SLITRK) and the L1 family.
DOI: 10.7554/eLife.12748.003
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Table 1. Proteins that are significantly reduced in the secretome upon Cre recombinase induced deletion of ADAM10. The table
contains the 42 most reduced proteins upon ADAM10 deletion. Indicated are the names of the proteins, the gene name, number of
unique peptides, topology, the mean of the ratio between neurons devoid of ADAM10 and neurons expressing endogenous levels of
ADAM10 of 5 biological replicates and the p-value calculated with a two-sided, heteroscedastic t-test based on the intensity ratios for
the control and the ADAM10 deletion condition. Protein names of previously published ADAM10 substrates are highlighted in italic
bold. (MEAN) Mean value of all 5 biological replicates, (SEM) Standard error of the mean. (Peptides) Number of peptides identified for
every protein. Gene symbols of proteins validated with immunoblot are marked bold.
Protein Name Gene Symbol Peptides Topology
MEAN
(A10KO/CON) TTEST
Matrix metalloproteinase-17 Mmp17 3 GPI 0,05 1,77E-03
Podocalyxin-like protein 2 Podxl2 3 Type-I 0,05 3,13E-03
Cadherin-10 Cdh10 4 Type-I 0,05 1,15E-03
Protocadherin-8 Pcdh8 16 Type-I 0,06 1,06E-03
SLIT and NTRK-like protein 1 Slitrk1 4 Type-I 0,08 8,52E-03
Sulfhydryl oxidase 2 Qsox2 3 Type-I 0,08 7,47E-03
Fractalkine Cx3cl1 2 Type-I 0,09 6,08E-03
Cell adhesion molecule 4 Cadm4 5 Type-I 0,09 1,11E-03
Poliovirus receptor-related protein 1 Pvrl1 3 Type-I 0,10 1,05E-02
Leucine-rich repeat and immunoglobulin-like domain-containing nogo Lingo2 2 Type-I 0,11 8,21E-04
Semaphorin-7A Sema7a 8 GPI 0,12 1,24E-02
Receptor-type tyrosine-protein phosphatase U Ptpru 6 Type-I 0,12 1,35E-02
Latrophilin-1 Lphn1 7 Type-I 0,13 2,81E-02
Neural cell adhesion molecule 1 Ncam1 16 Type-I/GPI 0,14 1,24E-03
Leucine-rich repeat-containing protein 4B Lrrc4b 16 Type-I 0,16 7,03E-04
Cell adhesion molecule 3 Cadm3 5 Type-I 0,16 2,30E-02
Low-density lipoprotein receptor Ldlr 13 Type-I 0,16 1,04E-02
Neuroligin-1 Nlgn1 5 Type-I 0,17 8,12E-04
Receptor-type tyrosine-protein phosphatase gamma Ptprg 4 Type-I 0,17 4,03E-03
H(+)/Cl(-) exchange transporter 3 Clcn3 2 Polytopic 0,19 7,17E-03
Cadherin-6 Cdh6 5 Type-I 0,19 7,46E-03
VPS10 domain-containing receptor SorCS1 Sorcs1 3 Type-I 0,23 2,96E-03
Neuronal growth regulator 1 Negr1 3 GPI 0,23 2,37E-02
Vesicular integral-membrane protein VIP36 Lman2 3 Type-I 0,25 2,86E-02
Receptor-type tyrosine-protein phosphatase kappa Ptprk 12 Type-I 0,26 1,12E-03
SLIT and NTRK-like protein 3 Slitrk3 3 Type-I 0,26 1,84E-02
Cell adhesion molecule 1 Cadm1 6 Type-I 0,26 3,85E-02
Transmembrane protein 132A Tmem132a 2 Type-I 0,26 1,52E-03
Immunoglobulin superfamily member 3 Igsf3 25 Type-I 0,27 8,04E-03
Protein tweety homolog 1 Ttyh1 5 Type-I 0,28 1,79E-02
Torsin-1A-interacting protein 1 Tor1aip1 5 Polytopic 0,29 2,62E-02
Protocadherin 9 Pcdh9 2 Type-II 0,29 3,15E-02
Protocadherin-20 Pcdh20 2 Type-I 0,30 3,28E-02
Plexin-B2 Plxnb2 4 Type-I 0,30 3,64E-02
Semaphorin-4B Sema4b 4 Type-I 0,32 3,98E-02
Neuronal cell adhesion molecule Nrcam 4 Type-I 0,33 4,91E-03
RGM domain family member B Rgmb 3 Type-I 0,35 1,06E-02
Chondroitin sulfate synthase 2 Chpf 2 Type-I 0,35 7,63E-03
Table 1 continued on next page
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shedding of PTPRU, PTPRG, PTPRK, PTPRS, PTPRT and PTPRD was reduced down to 12%, 17%,
26%, 40% and 43% and 42% respectively while shedding of NLGN1, NLGN3 and NLGN4 was
reduced down to 17%, 38% and 56% in the Neuroligin family. Interestingly, NLGN2 shedding was
not significantly affected upon ADAM10 knockout. Presynaptic Neurexins 2 and 3, binding partners
of Neuroligins, showed only a mild reduction in shedding upon ADAM10 deletion (Figure 1F) sug-
gesting that ADAM10 plays only a minor role in their proteolytic processing. Besides these families
ectodomain cleavage of member 1 and 3 of the SLITRK family was strongly reduced (Figure 1F).
Ectodomain cleavage of Protocadherin 8 and 9, which have been proposed to play a role in synapto-
genesis, was also reduced (Yasuda et al., 2007).
Axon targeting is another important physiological process, which contributes to proper function
of the brain. The L1 family, which consists of NgCAM-related cell adhesion molecule (NRCAM), L1
cell adhesion molecule (L1), Close homologue to L1 (CHL1) and Neurofascin has been proposed to
play a role in axon targeting and function. We observed that shedding of NRCAM was strongly
reduced down to 33%. Shedding of CHL1 was mildly reduced down to 60%. L1 shedding was
reduced down to 64% (Figure 1F), which is in agreement with their additional cleavage by the prote-
ase BACE1 (Kuhn et al., 2012). However, the reduction of L1 shedding did just not reach statistical
significance. Another axon targeting molecule whose ectodomain shedding was reduced upon
Adam10 deletion was Neogenin (NEO1), which belongs to the DCC family. Adam10 deletion also
resulted in reduced ectodomain cleavage of CADM1, 3 and 4 which are members of the Cellular
adhesion molecule family that has been proposed to play a role in axon myelination (Maurel et al.,
2007; Park et al., 2008). Interestingly, we identified the Low density lipoprotein receptor (LDLR) as
a substrate of ADAM10 whose ectodomain shedding was almost completely abolished. Finally, our
data revealed that ectodomain shedding of the GPI-anchored membrane-tethered matrix metallo-
protease 4 (MT4MMP/MMP17) depends to a great extent on ADAM10 activity.
Validation of selected substrate candidates by immunoblots
We validated selected ADAM10 substrate candidates with immunoblots. We focused on ADAM10
substrate candidates (marked with yellow rings in Figure 1C), where antibodies were available to
detect the reduction of the shed ectodomain in the conditioned medium of ADAM10-/- neurons as
this allowed a quantitative comparison to the proteomic SPECS analysis. Furthermore, we analyzed
full length protein levels to exclude that reduced ectodomain release simply resulted from a reduced
full length protein expression in Adam10 knockout neurons.
First, we verified successful Adam10 deletion upon iCre expression by immunoblot (Figure 2A,
ADAM10). Cre infection strongly reduced levels of immature and mature ADAM10 levels in the neu-
ronal cell lysate. Significantly reduced or almost abolished ectodomain levels confirmed ADAM10
cleavage of the previously described ADAM10 substrates Neuroligin-1 (NLGN1) and N-Cadherin
(CDH2) and matched the results in the SPECS experiment (Figure 2B), while their full length levels
were unchanged or slightly increased (Suzuki et al., 2012; Reiss et al., 2005). The following novel
ADAM10 substrate candidates were validated by immunoblots (Figure 2A): LDLR, MT4MMP,
LRRC4B, NRCAM, NEO1 and CNTN2. For all proteins ectodomain levels were reduced, while full-
length protein levels in the lysate were either unchanged or increased. Importantly, the quantitative
reductions of the ectodomain levels measured by immunoblots corresponded very well to the reduc-
tions measured by SPECS (Figure 2B), demonstrating the quantitative accuracy of SPECS.
Another protein, which was validated is L1 (Figure 2B). In ADAM10-/- neurons L1 shedding was
reduced by about 30%, both by SPECS and immunoblot (Figure 2B), demonstrating that in neurons
Table 1 continued
Protein Name Gene Symbol Peptides Topology
MEAN
(A10KO/CON) TTEST
Neogenin Neo1 27 Type-I 0,35 3,27E-03
Collagen alpha-1(XI) chain Col11a1 4 GPI 0,36 4,53E-02
Beta-1,3-galactosyltransferase 6 B3galt6 2 Type-II 0,38 4,85E-02
Neuroligin-3 Nlgn3 28 Type-I 0,38 2,97E-04
DOI: 10.7554/eLife.12748.004
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L1 is predominantly cleaved by a protease different from ADAM10. This is in line with previous
reports demonstrating that L1 is mostly cleaved by BACE1 in neurons (Kuhn et al., 2012;
Zhou et al., 2012), whereas it is mostly cleaved by ADAM10 in non-neuronal tissues and cell lines
(Riedle et al., 2009; Gavert et al., 2007; Maretzky et al., 2005).
For Cadherin-6 (CDH6) no antibody was available against the ectodomain, but an antibody
against the cytoplasmic C-terminus. Given that ADAM10 cleavage of a membrane protein does not
only lead to the secreted ectodomain, but also to the generation of a C-terminal, membrane bound
fragment (CTF), we detected the CDH6 CTF as a read-out of CDH6 cleavage by ADAM10. Hence,
we used an antibody directed against the CDH6 cytoplasmic domain and thus detected CDH6 full-
length protein and CDH6 C-terminal fragment (CTF) resulting from proteolytic cleavage in the cell
lysate. Adam10 deletion strongly reduced CDH6 CTF formation with CDH6 full-length protein levels
being unaltered (Figure 2A, CDH6), indicating that ADAM10 is required for CDH6 proteolysis. In
case of the Notch ligand Delta-Notch EGF receptor (DNER) we observed increased full-length pro-
tein levels in the cell lysate, which indicates that DNER is cleaved by ADAM10. However, the DNER
ectodomain was not detectable in directly loaded conditioned media of neurons. In case of fractal-
kine (CX3CL1) we confirmed its known cleavage by ADAM10 (Hundhausen et al., 2003) using a
sandwich ELISA to detect soluble fractalkine in conditioned media of neurons. Upon Adam10 dele-
tion, we observed a strong reduction of fractalkine ectodomain levels, which corresponded to our
prior quantified levels with the SPECS method (Figure 2B, CX3CL1).
Figure 2. Validation of ADAM10 substrates by immunoblot or ELISA. (A) Western blots of supernatants (sup, conditioned for 48 hrs) and cell lysates (lys)
of neurons expressing endogenous levels of ADAM10 (Con) or no active ADAM10 upon Cre-induced (Cre) ADAM10 knockout. ADAM10 blot shows
absent expression of ADAM10 in Cre-transduced neurons. Immunoblots are representative examples from n = 6 experiments. (B) Quantification of all
biological replicates of representative Western blots in A and comparison to the quantified relative intensity values of remaining shedding in the SPECS
experiment: Depicted is the mean of substrate ectodomain levels detected by immunblots of the supernatant under control (CON) and Adam10
knockout condition by Cre infection (Cre) and the corresponding standard error of the mean (SEM) of 6 biological replicates and p-value calculated
with a two-tailed, unpaired t-test. Additionally, we depicted the quantified reduction of ectodomain shedding including SEM and p-value of the SPECS
experiment. For CX3CL1 a sandwich ELISA was used to quantify the shedding products in the supernatant. (C) Quantification of the mean change in
the cell lysate upon ADAM10 deletion of 6 biological replicates including the standard error of the mean and comparison to the SPECS quantified
changes in the cellular glycoproteome of 5 biological replicates. For proteins that were also detected in the proteomic analysis of the cellular
membrane proteins (Figure 3), the proteomic (SPECS) data are also indicated in the graph.
DOI: 10.7554/eLife.12748.005
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Taken together, all membrane proteins analyzed by immunoblot could be validated as ADAM10
substrates. When we compared full length protein levels of all investigated proteins to the full length
protein levels quantified by mass spectrometry after their SPECS mediated enrichment described
below (Figure 3), we were able to detect for selected substrates the same increase in the mass spec-
trometry read out as observed in Western blot (Figure 2C).
Changes in membrane-bound glycoproteins upon ADAM10-deficiency
For the ADAM10 substrates investigated above, reduced shedding in ADAM10-/- neurons was
accompanied by unchanged or slightly increased full-length protein levels. For other substrate candi-
dates identified by SPECS no antibodies were available for validation by immunoblot. Thus, to be
independent of antibodies we complemented our SPECS analysis of the secretome by a similar anal-
ysis of the levels of membrane proteins in the neuronal membrane, which may provide additional val-
idation of more ADAM10 substrate candidates. An added value of this analysis is the opportunity to
identify membrane proteins that are not direct ADAM10 substrates, but whose protein levels are
instead indirectly changed. For example, it is conceivable that an ADAM10 substrate is part of a pro-
tein complex. Hence, its increased full-length protein levels upon ADAM10 deficiency might indi-
rectly stabilize the other complex partner, such as ion channels or neurotransmitter receptors.
Identical to the SPECS method intact neurons were labeled for 48 hr with ManNAz. Instead of
collecting the supernatant, labeled cells were then reacted with the biotinylated alkyne in order to
label the cellular glycoproteins carrying the modified sugar (Figure 3A). Because sialic acid – to
which ManNAz is converted - occurs as a terminal glycan modification in the Golgi, our approach is
not expected to label all cellular glycoproteins, but only mature glycoproteins within the Golgi and
beyond, including the plasma membrane. As the biotin-reagent is membrane-permeable, SPECS is
expected to label glycoproteins not only at the plasma membrane, but also in membranes of the
secretory and endocytic pathway. Using SPECS for labeling primary murine neurons, we identified
432 glycoproteins of which 37 were significantly changed upon Adam10 deletion considering a p-
value of less than 0.05 based on 4 biological replicates (Figure 3B, C, Table 2, Supplementary file
2 – A10 knockout surfaceome dataset). Applying multiple hypothesis testing none of the hits would
remain significantly changed. However, we could confirm increased levels of APP, CNTN2 and
L1CAM by Western blot (see below, Figure 4) indicating that correction for multiple hypothesis test-
ing was too strict. Of the 37 candidate proteins, 5 showed reduced levels, while 32 proteins had
increased levels (Table 2). 62% of the significantly changed proteins possessed a type-I topology
(Figure 3E) while 22% were polytopic proteins (Figure 3D). Among the significantly changed pro-
teins we found previously known substrates like APP, L1CAM or CX3CL1 (Figure 3E)
(Lammich et al., 1999; Kuhn et al., 2010; Hundhausen et al., 2003; Colombo et al., 2013;
Maretzky et al., 2005). Furthermore, we found substrate candidates that we had already identified
in the secretome of ADAM10 knockout neurons like ISLR2, CNTN2 or Neurexin 3 (Figure 2B, C).
NRCAM which showed increased levels in neurons after ADAM10 knockout in immunoblots
(Figure 2A) was borderline significant in the surface analysis. The small overlap of only 13 proteins
between significantly changed glycoproteins in the secretome and significantly changed glycopro-
teins in neurons upon ADAM10 knockout showed that ADAM10 cleavage regulated full-length pro-
tein levels only in a fraction of cases. Potentially, ADAM10 regulates substrate function by cleavage
mainly at the cell surface without affecting total full-length substrate levels, which instead may be
subject to lysosomal degradation.
Thus, for the majority of candidate ADAM10 substrates – identified in the secretome analysis –
the full-length cellular levels were neither significantly increased nor reduced upon ADAM10 deletion
which was also reported previously for the ADAM10 substrates Neuroglin-1 and N-cadherin
(Prox et al., 2013; Suzuki et al., 2012). We observed a mild but statistically significant accumulation
in the full-length protein levels of the presynaptically localized Neurexin family member NRXN3
which matches the observed concomitant mild modulation of shedding in the secretome. On the
contrary, full-length protein levels of postsynaptic Neurexin binding partners Neuroligin 1, 3 and 4
(NLGN-1/-3/-4) were not increased upon Adam10 deletion. Besides accumulation of full length pro-
tein levels of ADAM10 substrates, we additionally detected an accumulation of polytopic membrane
proteins like the ionotropic glutamate receptor GLUR1 that plays a role in excitatory synaptic trans-
mission and Reticulon-4 (RTN4) which has been implicated to play a role in axon outgrowth
(Schmandke et al., 2014). Furthermore, we detected membrane proteins, which accumulate in the
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Figure 3. Quantitative analysis of glycoproteins in the neuronal cell lysate of conditional Adam10-/- neurons. (A) Workflow for the identification of
alterations in the cellular glycoproteome upon Adam10 deletion in primary cortical neurons comprising plating, lentiviral infection, metabolic glycan
labeling, biotinylation of glycoproteins on intact neurons and affinity purification protocol and finally measurement via mass spectrometry. (B) Volcano
plot of the quantitative comparison between the cellular glycoproteomes of wild type (wt) and Adam10 knockout neurons of all glycoproteins identified
in 4 out of 4 experiments in the cellular glycoproteome of Adam10-/- and wt neurons. The p-value is depicted as negative decadic logarithm while the
fold-change (Adam10-/-/wt) is depicted as log2 value. Significantly changed protein: p0.05 (-log101.3). Additionally, we corrected for multiple
hypothesis testing with Benjamini Hochberg correction which gave a significance cut-off of p0.02. Substrates that are significantly reduced are marked
red. Proteins which were validated with immunoblot have a yellow ring. (C) Topology of all in four experiments identified glycoproteins in the cellular
glycoproteome of Adam10-/- and wildtype neurons. (D) Topology of identified glycoproteins with significantly increased protein levels in Adam10-/-
compared to wt neurons. (E) Overlap between proteins significantly reduced in the secretome and proteins significantly increased in the cellular
glycoproteome.
DOI: 10.7554/eLife.12748.006
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Table 2. Proteins that are significantly changed in the cellular glycoproteome upon Cre recombinase induced deletion of ADAM10.
The table contains all significantly changed proteins upon ADAM10 deletion. Indicated are the names of the proteins, the gene name,
number of unique peptides, the mean of the ratio between neurons devoid of ADAM10 and neurons expressing endogenous levels of
ADAM10 of 4 biological replicates and the p-value calculated with a two-sided, heteroscedastic t-test based on the relative label-free
quantification ratios (LFQ) for the control and the ADAM10 deletion condition. Gene Symbols of previously published ADAM10
substrates are highlighted in bold. (MEAN) Average change between A10 deleted (A10KO) and Control (CON) cells of 4 biological
replicates, (SEM) Standard error of the mean. (Peptides) Number of Peptides identified for every protein.
Protein Name Gene Symbol Peptides Topology
MEAN
(A10KO/CON) TTEST
Isoform APP695 of Amyloid beta A4 protein App 15 Type I 3,71 1,30E-02
Fractalkine Cx3cl1 6 Type I 2,91 3,00E-03
Protein Ptprz1 Ptprz1 25 Type I 2,41 1,66E-03
Receptor-type tyrosine-protein phosphatase U Ptpru 7 Type I 2,10 7,82E-03
Immunoglobulin superfamily containing leucine-rich repeat protein 2 Islr2 16 Type I 1,89 6,18E-03
Semaphorin-4B Sema4b 4 Type I 1,81 2,36E-02
Contactin-associated protein-like 4 Cntnap4 17 Type I 1,65 3,55E-02
Fibronectin leucine rich transmembrane protein 3 Flrt3 16 Type I 1,64 5,05E-02
Netrin receptor UNC5D Unc5d 5 Type I 1,61 4,66E-02
Neural cell adhesion molecule L1 L1cam 33 Type I 1,61 1,12E-02
Voltage-dependent L-type calcium channel subunit beta-1 Cacnb1 9 Type I 1,60 2,78E-02
Phospholipase D3 Pld3 3 Type II 1,60 4,49E-02
Melanoma inhibitory activity protein 3 Mia3 23 Type I 1,55 2,04E-02
Receptor-type tyrosine-protein phosphatase kappa Ptprk 12 Type I 1,53 2,41E-02
Tetraspanin-7 Tspan7 5 Polytopic 1,49 1,63E-02
Protein Pcdhgb6 Pcdhgb6 9 Type I 1,49 9,66E-03
Serine/threonine-protein kinase LMTK3 Lmtk3 19 Type I 1,47 2,53E-02
Protocadherin-8 Pcdh8 32 Type I 1,46 2,73E-03
Protein Pcdha9 Pcdha9 12 Type I 1,43 3,90E-02
Glutamate receptor 1 Gria1 21 Type I 1,42 1,00E-02
Tenascin-R Tnr 17 Secreted 1,40 4,69E-03
Neurocan core protein Ncan 6 Secreted 1,35 7,81E-03
Protein disulfide-isomerase A6 Pdia6 7 Secreted 1,34 5,00E-02
Contactin-2 Cntn2 18 GPI 1,30 1,87E-02
Receptor-type tyrosine-protein phosphatase F (Fragment) Ptprf 19 Type I 1,30 4,74E-02
Reticulon-4 Rtn4 39 Polytopic 1,28 2,94E-04
Isoform 2 of Seizure protein 6 Sez6 6 Type I 1,27 3,76E-02
Large neutral amino acids transporter small subunit 1 Slc7a5 9 Polytopic 1,25 1,50E-03
Cell adhesion molecule 4 Cadm4 10 Type I 1,23 3,02E-02
Transferrin receptor protein 1 Tfrc 22 Type II 1,18 3,52E-02
Cadherin EGF LAG seven-pass G-type receptor 3 Celsr3 35 Type I 1,16 1,37E-02
Protocadherin Fat 4 Fat4 48 Type I 1,12 3,05E-02
Sodium/potassium-transporting ATPase subunit alpha-3 Atp1a3 62 Polytopic 0,95 4,09E-02
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 Atp2a2 52 Polytopic 0,86 2,14E-02
Slc8a1 protein Slc8a1 24 Polytopic 0,85 3,18E-02
Synaptic vesicle glycoprotein 2A Sv2a 15 Polytopic 0,85 6,99E-03
Solute carrier organic anion transporter family member 3A1 Slco3a1 4 Polytopic 0,75 8,95E-03
DOI: 10.7554/eLife.12748.007
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Figure 4. Analysis of proteolytic cross talk of ADAM10 and BACE1 for selected substrates. (A) Representative
Western blots of 48 hr conditioned supernatants and cell lysates of ADAM10 fl/fl neurons treated with or without
C3 to inhibit BACE1 and infected with a control virus (Con) or Cre recombinase virus (Cre) to delete Adam10. A
representative ADAM10 blot shows abolished expression of immature and mature ADAM10. (B) Quantification of
the mean reduction in ectodomain shedding in the conditioned medium (sup: supernatant), the respective
standard error of the mean (SEM) and the significance of six biological replicates calculated with a two-tailed
heteroscedastic t-test. A10: ADAM10. (C) Quantification of the mean increase of selected substrates in the cellular
glycoproteome (lys: lysate), the respective standard error of the mean (SEM) and the significance of 6 biological
replicates calculated with a two-tailed heteroscedastic t-test. (D) Brain membrane immunoblots from Adam10fl/fl
and CamkII-Cre Adam10fl/fl mice which have lost ADAM10 expression in excitatory neurons, but not in other
neurons and non-neuronal cells.
DOI: 10.7554/eLife.12748.008
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cellular glycoproteome but were not detected in the secretome like LRRTM1 that has been impli-
cated to play a role in modulating the synapse architecture (Soler-Llavina et al., 2013). Hence,
changes in shedding of a given protein do not necessarily result in accumulation of its precursor in
the membrane and, conversely, accumulation of a given protein can also be caused indirectly.
Cross-talk between ADAM10 and BACE1
Some of the significantly changed proteins in the secretome as well as in the cellular glycoproteome
analysis were previously also identified as BACE1 substrates, such as L1, CHL1 and contactin-2. This
suggests a potential cross-talk between both proteases and raises the possibility of redundancy
between ADAM10 and BACE1 for the cleavage of some of its substrates. To test this possibility, we
used immunoblots and analyzed cellular full-length protein levels as well as ectodomain levels in
response to BACE1 inhibition, Adam10 deletion or a combination of both (Figure 4A). We investi-
gated ectodomain cleavage and cellular levels of 11 substrates (CHL1, L1, CNTN2, NLGN1, NRCAM,
LDLR, CDH2, MT4MMP, SEZ6, APP, NEO1), which we selected according to their quantitative reduc-
tion in ectodomain shedding in the current ADAM10 and the previous BACE1 SPECS study
(Kuhn et al., 2012). We selected substrates that were predominantly (NLGN1, NRCAM, MT4-MMP)
or partially (CDH2, NEO1) cleaved by ADAM10 or that are predominantly cleaved (SEZ6) and par-
tially cleaved by BACE1 (APP, CHL1, L1, CNTN2). Blotting for ADAM10 confirmed deletion of
Adam10 upon lentivirus-mediated expression of Cre recombinase (Figure 4A). This was further cor-
roborated by abolishment of sAPPa in ADAM10 deleted neurons. BACE1 inhibition was monitored
with the abolishment of sAPPb (Figure 4A, B) and led to a compensatory increase in sAPPa which
previously has been described (Colombo et al., 2013).
SEZ6 ectodomain cleavage was almost abolished and its cellular levels were increased exclusively
upon BACE1 inhibition with the validated inhibitor C3, which shows that SEZ6 ectodomain cleavage
is predominantly cleaved by BACE1, in agreement with a previous study (Kuhn et al., 2012). How-
ever, CDH2, NRCAM, NLGN1, MT4MMP, NEO1 and LDLR ectodomain levels were reduced and
their full length protein levels in some cases increased exclusively upon Adam10 deletion while
simultaneous BACE1 inhibition had no additional effect. In contrast to the L1 family member
NRCAM, Adam10 deletion and BACE1 inhibition had an additive effect in the reduction of ectodo-
main cleavage and accumulation of full length protein levels for the members CHL1 and L1CAM in a
similar fashion as for APP (Figure 4A, B). This also held true for CNTN2. However, in case of APP
the lack of BACE1 cleavage seems to be compensated by ADAM10, which does not appear to be
the case for CHL1, L1CAM or CNTN2. In summary, the 11 investigated substrates can be subdivided
into three classes, namely predominant ADAM10 substrates, predominant BACE1 substrates and
substrates which are cleaved by ADAM10 and BACE1, demonstrating that there is a cross-talk
between ADAM10 and BACE1 for some but not all substrates.
Finally, we tested whether the substrates identified in neurons would also be cleaved by
ADAM10 in vivo. Therefore, we analyzed the brain membrane fraction of conditional Adam10 knock-
out mice that had been crossed with a postnatal neuron-specific CamKII-Cre driver line at P20
(Prox et al., 2013). Due to technical limitations we were only able to analyze the membrane fraction
of ADAM10 knockout brains. We observed a 50% reduction of total ADAM10 in the brain mem-
brane fraction, which is in line with the excitatory neuron-specific CamkII-Cre driver line sparing
GABAergic neurons and the fact that ADAM10 besides neurons is also expressed in glial cells. Simi-
lar to our in vitroexperiments with primary cortical neurons full-length levels of NLGN1 were not
changed in brain membrane extracts. In contrast to NLGN1, we observed a clear increase of full-
length protein levels for NEO1, NRCAM, CHL1 and MT4-MMP (Figure 4D) similar to what we had
observed previously in neuronal lysates upon Adam10 deletion (Figures 2A,4A). As expected, the
predominant BACE1 substrate SEZ6 showed no change upon Adam10 deletion (Figure 4D).
Altered connectivity in olfactory bulb of Adam10-/- mice
Several of the newly identified ADAM10 substrates, including the newly identified substrates
NRCAM and CHL1, have functions in axon targeting (Demyanenko et al., 2011; Heyden et al.,
2008; Montag-Sallaz et al., 2002). Thus, it appears possible that Adam10-/- mice present defects in
brain connectivity. To test this we analyzed P20 conditional Adam10fl/fl knockout mice that had
been crossed with a postnatal neuron-specific CamKII-Cre driver line, resulting in forebrain specific
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Adam10 deletion in excitatory neurons, while the cerebellum is not affected (Prox et al., 2013;
Casanova et al., 2001). Brain areas, where connectivity changes can be well studied, are the olfac-
tory bulb and the hippocampus. Staining of olfactory glomeruli in the olfactory bulb with the plant
lectin DBA revealed 40% of diffuse olfactory glomeruli in Adam10-/- mice compared to 10% diffuse
olfactory glomeruli in control Adam10fl/fl mice. Additionally, individual axons (white arrows) that
seemed to project to two glomeruli, were detected in the ADAM10-/-, but not in control mouse
olfactory bulbs (Figure 5A). Such mistargeted projections have previously been observed in mice
lacking our newly identified ADAM10 substrate NRCAM or lacking the BACE1 substrate CHL1 and
may result from mistargeted axons that have not been correctly eliminated during development
(Heyden et al., 2008).
Staining in the hippocampus for the synaptic marker protein synatophysin revealed additional
changes in ADAM10-/- mice. Synaptophysin stains synaptic terminals of mossy fibers, which project
from the dentate gyrus to the dendritic arbor of hippocampal pyramidal cells in CA3 (Figure 5C). In
control mice the pyramidal somata were not stained and clearly separated from synaptophysin stain-
ing in the stratum lucidum. This separation was lost in Adam10-/- mice, where a significantly
increased number and area of synaptophysin positive mossy fiber terminals in the pyramidal layer
revealed aberrant mossy fiber projections on hippocampal pyramidal somata in CA3 (Figure 5D).
Interestingly, this phenotype is also observed in mice lacking the ADAM10 substrate NCAM
(Cremer et al., 1998) and in mice lacking CHL1 (Montag-Sallaz et al., 2002), which is a substrate
for both ADAM10 and BACE1 (Heyden et al., 2008). Taken together, these results reveal mistar-
geted axons in the hippocampus and olfactory bulb of Adam10-/- mice which may result from
impaired processing of NRCAM, CHL1 and NCAM.
Other ADAM10 substrates, including APP and NLGN1, have physiological roles in brain develop-
ment, for example in synapse formation/plasticity (Ring et al., 2007; Weyer et al., 2014;
Suzuki et al., 2012; Heyden et al., 2008; Montag-Sallaz et al., 2002; Brennaman et al., 2013;
Hick et al., 2015). In fact, one of the previously reported phenotypes in ADAM10-/- brains are syn-
aptic alterations. In the stratum radiatum of hippocampal region CA1 in ADAM10-deficient but not
in wild-type mice, enlarged stubby dendritic spines filled with mitochondria were observed
(Prox et al., 2013). Interestingly, APP also has a role in synapse formation and maintenance, sug-
gesting that loss of the ADAM10 cleavage product sAPPa in ADAM10-/- mice may be responsible
for their synaptic alterations. To this end we crossed ADAM10-/- mice with sAPPa knockin (sAPPaki)
mice that do no longer express APP-FL but solely the secreted APPsa ectodomain due to a stop
codon insertion into the mouse APP locus behind the a-secretase cleavage site (Ring et al., 2007).
However, knock-in of sAPPa in ADAM10 -/- mice, confirmed by Western blot analysis (Figure 6A),
as well as ultrastructural analysis (Figure 6B) failed to rescue this synaptic phenotype, demonstrating
that dysregulation of another or even several different ADAM10 substrates cause the deficits in syn-
aptic morphology and function. Additionally, increased astrocytic activation demonstrated by
enhanced GFAP expression could not be rescued by sAPPa expression (Figure 6A).
Discussion
Ectodomain shedding of membrane proteins is a fundamental mechanism to control intercellular
communication, the interaction between cells and their environment. Our study demonstrates that
ADAM10 is a major shedding enzyme in the nervous system and that a loss of ADAM10 leads to
defects in neuronal connectivity.
The metalloprotease ADAM10 plays manifold roles in development and disease. Studying
ADAM10 substrates in primary cells or tissue has not been possible until the advent of conditional
Adam10 knockout mice as constitutive Adam10 knockout mice die latest at embryonic day 9.5
(E9.5). These mice succumb to malformations like a retarded heart development, extracorporeal for-
mation of blood vessels and improper formation of somites, which are considered to result from a
lack in proteolytic processing of Notch by ADAM10 (Hartmann et al., 2002; Jorissen et al., 2010;
Krebs et al., 2000; Kageyama and Ohtsuka, 1999). However, postnatal neuron-specific disruption
of Adam10 in the brain leads to impaired learning, defects in long term potentiation and seizures
which are considered to result from defects in synapse function and architecture and microglial and
astrocytic activation (Prox et al., 2013). These phenotypes point to an important postnatal function
of ADAM10 via cleavage of additional substrates beyond Notch. So far, Notch and other ADAM10
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Figure 5. Axon targeting and synaptic alterations in ADAM10 deficient mice (A) Olfactory nerve axons in adult
ADAM10-deficient mice. Confocal microscopy picture of olfactory bulb frontal sections stained for the detection of
the olfactory nerve axons labeled with the plant lectin DBA conjugated to biotin (in magenta). Cell nuclei labeled
with DAPI appear in green. In wild-type mice (upper panel), olfactory nerve terminals generally project to only one
olfactory glomerulus (AD10-fl/fl). In contrast, in ADAM10-deficient mice (AD10-fl/fl+CamkII-Cre) (lower panel),
some olfactory axons terminate in two glomeruli or pass through the glomerular layer and terminate in the
external plexiform layer. In addition, the arborizations of some olfactory axons extend outside a particular olfactory
glomerulus. (B) Quantification of olfactory glomeruli morphology in adult ADAM10-deficient mice. In wild-type
mice the majority (~90%) of glomeruli stained with the lectin DBA display a compact defined morphology. In
ADAM10-deficient mice (AD10-fl/fl+CamkII-Cre), significantly less glomeruli are compact and many glomeruli
appear more diffuse. (C) Mossy fiber organization in adult ADAM10-deficient mice. Sagittal sections stained for
the presence of synaptophysin (red). Confocal microscopy showing the distribution of mossy fiber terminals in the
CA3 subfield of the hippocampus. In wild-type mice (AD10-fl/fl) (upper panel) the mossy fibers are organized in
the infra-inter (IIP-MF) and supra (SP-MF) pyramidal bundles both terminating in large synaptic boutons on
Figure 5 continued on next page
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substrates like N-Cadherin, fractalkine, Neuroligin-1 or E-Cadherin have already been described
(Hundhausen et al., 2003; Suzuki et al., 2012; Reiss et al., 2005; Maretzky et al., 2005). However,
only few substrates like N-Cadherin, Neuroligin-1, Notch-1 and Notch-2 have been shown to be
cleaved in primary cells like neurons due to the aforementioned embryonic lethality of constitutive
Adam10 knockout mice and the lack of conditional Adam10 knockout models until recently
(Prox et al., 2013; Suzuki et al., 2012; Zheng et al., 2012).
Here, we provide the first systematic analysis of ADAM10 substrates in primary cortical neurons
of a conditional Adam10 knockout mouse. Applying SPECS to enrich newly synthesized glycopro-
teins from conditioned media and the cell surface of primary neurons we identified more than 300
glycoproteins in the secretome, which is slightly more than in our previous study identifying BACE1
substrates in neurons (Kuhn et al., 2012). Additionally, we identified and quantified more than 400
membrane glycoproteins on or close to the cell surface of neurons which is 10 times more mem-
brane proteins than in a previous study where cell surface biotinylation was used, but without the
SPECS labeling (Sanz et al., 2015). This demonstrates the power of the metabolic SPECS labeling to
an in-depth quantification of the neuronal membrane proteome. Our analysis revealed that almost
50% of all membrane proteins released into the secretome are reduced upon Adam10 deletion of
which 70% possess a type-I topology. Furthermore, we found that 13 secreted proteins like clusterin
were reduced. Because ADAM10 cleaves membrane-bound substrates, the reduced clusterin levels
are likely to be the consequence of secondary effects such as an increased internalization due to sta-
bilization of its surface receptor in ADAM10-deficient neurons. The large number of substrates
makes ADAM10 a major sheddase in the nervous system and an important modifier of the neuronal
secretome. Among the candidate ADAM10 substrates in the secretome we could identify whole pro-
tein families having roles in synapse function and architecture. Their reduced cleavage upon
Adam10 deletion fits to the phenotypes described in neuron-specific conditional Adam10 knockout
mice, including defects in long term potentiation and seizures (Prox et al., 2013). For example, Neu-
rexins and Neuroligins are known to form trans-synaptic complexes which are especially necessary
for synapse function (Figure 7) (Bang and Owczarek, 2013; Su¨dhof, 2008). Adam10 ablation
caused a strong reduction in ectodomain shedding of postsynaptic NLGN1, 3 and slightly less pro-
nounced for NLGN4. Hence, shedding of Neuroligins might negatively regulate their synaptic func-
tion (Suzuki et al., 2012). Surprisingly, NLGN2 shedding was not affected by Adam10 deletion,
which might be explained by the distinct roles played by these proteins. In fact, NLGN1 and 3 con-
tribute to the function of excitatory, glutamatergic synapses while NLGN2 contributes to the func-
tion of inhibitory, GABAergic synapses (Kang et al., 2014) suggesting that ADAM10 might
preferably be involved in the modulation of glutamatergic, excitatory but not GABAergic inhibitory
synapse functions. This is additionally supported by the fact that the ionotropic glutamate receptor
GLUR1 (Gria1), previously described to be modulated by synaptic NLGN1 levels
(Wittenmayer et al., 2009), was increased in the cellular glycoproteome upon Adam10 deletion
while GABA receptors which are known to interact with NLGN2 were not increased (Kang et al.,
2014). Besides the reduction of NLGN1, 3 and 4 shedding, Adam10 deletion resulted in a concomi-
tant shedding reduction of the NLGN receptors NRXN 2 and 3 while the full length NRXN precursors
mildly accumulated in the cellular glycoproteome. We additionally observed reduced ectodomain
shedding for almost all members of the receptor tyrosine phosphatase family (PTPR) and the Slit and
receptor tyrosine kinase domain (SLITRK) family which both play roles in synapse function and forma-
tion (Figure 7) (Um et al., 2014; Yim et al., 2013). Specific members of both families like for exam-
ple PTPRD and SLITRK3 have been shown to interact with each other transsynaptically (Um et al.,
Figure 5 continued
pyramidal cell dendrites in the stratum lucidum (sl) of the CA3. CA3 can be clearly distinguished from the stratum
pyramidale (sp) containing the pyramidal cell bodies and small synatophysin positive inhibitory synapses. In
ADAM10-deficient mice (AD10-fl/fl+CamkII-Cre) (lower panel), mossy fiber terminals are also detected throughout
the sp surrounding the pyramidal cell soma. (D) Quantitative comparison of mossy fiber terminals in the stratum
lucidum with respect to number and size between adult wild type and ADAM10-deficient mice. Large
synaptophysin-labeled puncta indicative for mossy fiber synaptic boutons are significantly more frequent in the
stratum lucidum of ADAM10-deficient mice (AD10-fl/fl+CamkII-Cre).
DOI: 10.7554/eLife.12748.009
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Figure 6. Synaptic alterations in ADAM10 deficient mice are not rescued by APPsa overexpression (A) Mice deficient for ADAM10 in adult brain
(ADAM10-fl/fl+CamkII-Cre) and transgenic for a sAPPa knockin into the APP locus (ADAM10ko sAPPki) thus expressing only sAPPa, were generated by
crossing sAPPa knockin mice (sAPPki) and ADAM10-fl/fl+CamkII-Cre knockout mice (ADAM10ko) for two generations. Immunoblot analysis of extracts
from cortex, cerebellum and hippocampus from 21 days old mice revealed that ADAM10-expression was clearly reduced in cortex and hippocampus of
conditional ADAM10 knockout mice (A10fl/fl, CamkII-Cre pos.). No reduction of ADAM10 was observed in cerebellum since this tissue was not targeted
by the CamkII-Cre driver. The proform (pADAM10: 100 kDa) and the mature form (mADAM10: 70kDa) of ADAM10 are depicted. Expression of sAPPa
(105 kDa) was detectable in sAPPa transgenic mice (sAPPki +) but absent in wild type mice. Full length APP (APPfl) (105 kDa) expression was lost in
sAPPa knockin mice but is present in wild type mice. As reported (Prox et al., 2013) GFAP (45 kDa) expression in cortex of 21 days old brains was
increased in the ADAM10 knockout mice (ADAM10 ko). This pathology was not reversed upon sAPPa expression (sAPPki +), hinting to an ongoing
Figure 6 continued on next page
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2014; Takahashi et al., 2012). While SLITRK1, 2, 4 and 5 and PTPRS have been implicated in the for-
mation of excitatory synapses, SLITRK3 and PTPRD seem to be involved in the formation of inhibi-
tory synapses (Yim et al., 2013).
Impaired cognitive functions can also result from impaired axon targeting and function leading to
impaired signal transmission and wrong connection of cortical regions in the brain. We observed
mistargeted axons of the olfactory epithelium projecting instead of usually to one olfactory glomeru-
lus to two olfactory glomeruli in the olfactory bulb of ADAM10-deficient mice. Similar axon targeting
phenotypes have also been reported upon knock-out of L1 family members Nrcam and Chl1 while
L1 knockout mice succumb to the much more severe CRASH syndrome with corpus callosum
Figure 6 continued
astrogliosis. (B) High resolution electron micrographs of spines in the hippocampal CA1 stratum radiatum from 21 days old mice. Conditional ADAM10
deficiency (ADAM10ko) leads to enlarged and stubby spines (light red shaded). The presence of sAPPa (sAPPki) in ADAM10 knockout mice is not
sufficient to rescue the alterations in spine morphology. In wildtype hippocampus spines are characterized as tiny spine heads with no organelles. Scale
bars: 1 mm.
DOI: 10.7554/eLife.12748.010
Figure 7. Overview of subcellular localization and interaction partners of ADAM10 substrates. Overview of the subcellular localization and interaction
partners of selected substrates of ADAM10 and their respective behavior in terms of ectodomain shedding and cellular amount upon Adam10 deletion.
Upper symbol refers to ectodomain shedding while lower symbol indicates the cellular levels of the protein.
DOI: 10.7554/eLife.12748.011
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hypoplasia and mental retardation (Heyden et al., 2008; Montag-Sallaz et al., 2002;
Demyanenko et al., 2011; Kolata et al., 2008). Indeed, we observed reduced ectodomain shed-
ding of all L1 family members (L1, CHL1, NRCAM and Neurofascin (NFASC)) with NRCAM shedding
being reduced the strongest. In contrast, shedding of L1 and CHL1, previously identified as major
substrates of BACE1 in neurons (Kuhn et al., 2012; Zhou et al., 2012) were only mildly modulated
upon ADAM10 knockout in line with previous data that demonstrate cleavage of CHL1 and L1 by
metalloproteases in non-neuronal cells (Maretzky et al., 2005; Naus et al., 2004). Simultaneous
BACE1 inhibition and Adam10 knockout resulted in a further reduction of ectodomain shedding of
CHL1 and L1 in a similar fashion to APP (Colombo et al., 2013; Zhou et al., 2012). While for L1 dif-
ferential functional outcomes of ADAM10 and BACE1 cleavage have not been investigated so far, it
recently has been shown that CHL1 cleavage by BACE1 is indispensible for Semaphorin 3a induced
axon repulsion while inhibition of metalloprotease mediated CHL1 cleavage had no impact which
suggests that modulation of axon growth in the axonal or presynaptic compartment via CHL1 is only
modulated by BACE1 (Bara˜o et al., 2015). Interestingly, as shown here for conditional ADAM10
knockout CamKII-Cre mice, misplaced hippocampal mossy fiber terminals were also observed in
CHL1- or NCAM-deficient (Colombo et al., 2013; Yasuda et al., 2007) but also in BACE1-deficient
mice (Hitt et al., 2012). Likewise, CHL1-, NrCAM-, BACE1-, or ADAM10-deficiency all result in mis-
targeted axons in olfactory glomeruli (Montag-Sallaz et al., 2002), which may indicate functions for
the refinement of connectivity (Montag-Sallaz et al., 2002). Nevertheless, other identified sub-
strates, such as neogenin (NEO1) and contactin-2 (CNTN2) may also contribute (Denaxa et al.,
2005; Braisted et al., 2000), which makes a substrate phenotype correlation difficult.
Conditional Adam10 knockout mice also show activated microglia upon postnatal, neuronal dele-
tion of Adam10 (Prox et al., 2013). One important chemokine expressed by neurons is fractalkine
(CX3CL1) which has previously been proposed to be cleaved by ADAM10 and ADAM17
(Hundhausen et al., 2003; Garton et al., 2001). Abolished constitutive shedding of CX3CL1 and
increased CX3CL1 full length protein levels in neurons upon knockout of ADAM10 demonstrate that
ADAM10 regulates CX3CL1 levels in neurons (Figure 3B). The biological role of ADAM10 cleaved
soluble CX3CL1 might be a reduction of microglial activation leading to neuroprotection. This is sup-
ported by the finding that microglial activation and neuronal cell death in the substantia nigra upon
MPTP treatment are increased in a CX3CL1 knockout mouse model and can be rescued by soluble
but not membrane bound CX3CL1 suggesting a neuroprotective role of soluble CX3CL1
(Ueno et al., 2013; Nash et al., 2013; Morganti et al., 2012).
We also identified low density lipoprotein receptor (LDLR) as a novel substrate of ADAM10. LDLR
has been described to undergo induced release upon treatment with the phorbolester PMA and its
c-terminal fragment is subject to intramembrane proteolysis by g-secretase (Tveten et al., 2013).
Here, we show that constitutive shedding of LDLR is catalyzed by ADAM10. Soluble LDLR has been
shown to be able to bind to LDL. However, functional consequences of ADAM10 catalyzed cleavage
of LDLR like an altered LDL uptake have not been investigated so far.
Another important finding was that in contrast to other proteases like ADAM17 or ADAM9
(Kuhn et al., 2010), cellular levels of the GPI-anchored, neuronally expressed metalloprotease
MT4MMP increased while MT4MMP ectodomain shedding was abolished upon Adam10 deletion
(Rikimaru et al., 2007). MT4MMP is assumed to mostly cleave soluble proteins in the extracellular
matrix (Itoh, 2015). However, since little is known about the physiological substrate spectrum of
MT4MMP in neurons, we cannot exclude that some of our observed changes in the ADAM10-/- neu-
rons and their secretome may be an indirect consequence of the reduced MT4MMP shedding.
Our data revealed that some proteins are exclusive substrates of ADAM10 (NRCAM, CX3CL1)
while others are exclusively cleaved by BACE1 (SEZ6, APLP1). Finally, there is a group of proteins
that can be cleaved by both proteases (APP, CHL1, L1). This specificity may result from differential
sorting of the substrates towards the pre- and postsynaptic compartment, or from primary sequence
constraints in the juxtamembrane region. However, this classification will be extended in the future
as substrates of other in neuron expressed proteases like MT4MMP and MT5MMP have not been
determined in the brain yet (Rikimaru et al., 2007; Jaworski, 2000).
Taken together, the identification of novel ADAM10 substrates demonstrates that ADAM10 has a
large spectrum of neuronal substrates, but the ADAM10 substrate repertoire is presumably even
larger. For example Notch1, an established ADAM10 substrate, was not detected in our analysis,
potentially because its expression level was below the detection limit or because it was not
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expressed in the neurons at the time-point of analysis or because its ADAM10-mediated shedding is
ligand-dependent. Additionally, while we identified ADAM10 substrates in neurons, ADAM10 is also
expressed in astrocytes and oligodendrocytes and certain proteins are expressed at later develop-
mental stages than what we have investigated (Sakry et al., 2014; Ludwig et al., 2005). Further-
more, it is possible that certain biological effects of Adam10 deletion cannot be investigated in
dissociated in vitro cultures of neurons but require the context of brain tissue to provide the correct
extracellular matrix and tissue architecture, which is provided by slice cultures or even better in vivo.
In summary, our study demonstrates that ADAM10 is a major sheddase in the brain and is
required for correct axon targeting in the olfactory bulb and the hippocampus of conditional
ADAM10-/- mice. The newly identified substrates demonstrate that ADAM10 has a fundamental role
in the brain and provide a molecular explanation for cognitive deficits, seizures and axon mistarget-
ing in neuron-specific ADAM10 knockout mice. Finally, these findings will also aid the prediction of
potential side effects of ADAM10-activating drugs as they are considered for the treatment of AD
and prion disease.
Materials and methods
Antibody production in rat
Antibodies against murine CHL1 (clone 7B2, IgG2A) and murine Neogenin (NEO1) (clone 21A8
IgGG1) were produced by fusing murine CHL1 ectodomain (aa26-1006) and murine Neogenin ecto-
domain (aa45-1101) to an N-terminal CD5 signal peptide and a C-terminal 2XStrepII tag which sub-
sequently were expressed in HEK293T cells. Recombinant ectodomain was purified from 300 ml
conditioned media with 300 ml Streptactin sepharose (IBA GmbH, Go¨ttingen, Germany) according to
the instructions of the manufacturer. 50 mg of each purified fusion protein (mCHL1-2XStrepII,
mNEO1-2XStrepII) were injected intraperitoneally (i.p.) and subcutaneously (s.c.) into LOU/C rats
using incomplete Freund’s adjuvant supplemented with 5 nmol CpG 2006 (TIB MOLBIOL, Berlin,
Germany). After a six week interval a final boost with 50 mg hAPP and CpG 2006 was given i.p. and
s.c. three days before fusion. Fusion of the myeloma cell line P3X63-Ag8.653 with the rat immune
spleen cells was performed according to standard procedures. Hybridoma supernatants were tested
in a solid-phase immunoassay with mCHL1-2XStrepII, mNEO1-2XStrepII or an irrelevant StrepII
fusion protein coated to ELISA plates. Antibodies from tissue culture supernatant bound to mCHL1-
2XStrepII or mNEO1-2XStrepII were detected with HRP conjugated mAbs against the rat IgG iso-
types (TIB173 IgG2a, TIB174 IgG2b, TIB170 IgG1 all from ATCC, R-2c IgG2c homemade), thus
avoiding mAbs of IgM class. HRP was visualized with ready to use TMB (1-StepTM Ultra TMB-ELISA,
Thermo, Braunschweig, Germany). MAbs that reacted specifically with mCHL1-2XStrepII or mNEO1-
2XStrepII were further analyzed in non-reducing Western blot and immunocytochemistry.
Antibody production in chicken
Murine DNER ectodomain (aa26-620) was fused to an N-terminal CD5 signal peptide and a C-termi-
nal biotin accepting peptide and 6XHIS tag. This construct was expressed in HEK293T cells with bio-
tin ligase (BirA) fused to an N-terminal CD5 signal peptide and a C-terminal KDEL endoplasmic
reticulum (ER) retention motif to target BirA to the ER. Recombinant ectodomain was purified from
serum free media with a 1 ml Nickel NTA column (GE Health Care, Solingen, Germany) according to
the instructions of the manufacturer. Briefly, the column was equilibrated with 5 column volumes
(CV) 5 mM Imidazol in phosphate buffered saline (PBS), 300 ml serum free media containing the
recombinant protein and supplemented with 5 mM Imidazol were loaded on the column at a flow
rate of 2 ml/min. Afterwards the column was washed with 5 CV 5 mM Imidazol in PBS. Bound DNER-
BAP/HIS was eluted with 5 CV 200 mM Imidazol in PBS. LSL chicken hatching eggs were obtained
from LSL Rhein-Main (Gut Heinrichsruh, Berglern). Birds were hatched and raised at the Institute for
Animal Physiology, Department of Animal Science, LMU Munich. The birds were fed ad libitum with
a standard chicken diet. At an age of eight months hens were immunized i.m. with 300 mg purified
DNER protein mixed with Freund’s adjuvant complete (Sigma-Aldrich, Munich, Germany). Birds were
boosted i.m. with 300 mg protein plus Freund’s incomplete adjuvant (Sigma-Aldrich) three weeks
after the initial immunization. Eggs were collected two weeks after the boost for a period of two
weeks. Animal experiments were authorized by the Regierung von Oberbayern (55.2-1-54-2532.6-
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12-09). DNER chicken antibodies were purified by antigen affinity purification. 300 mg DNER-BAP-
HIS was bound to 300 ml streptavidin bead slurry (50% w/v). The purified immunoglobulin fraction of
chicken egg yolk was loaded on the DNER-BAP-HIS Streptavidin column to isolate DNER specific
antibodies. Bound DNER antibodies were eluted with acidic elution at pH 2.5.
Antibodies from commercial or academic sources
The following antibodies were used in this study: ADAM10 (Abcam/Epitomics, Cambridge, UK,
EPR5622), Actin (Sigma-Aldrich, A2066), sAPPa 5G11 (Colombo et al., 2013), sAPPb 8C10
(Kuhn et al., 2010), APP 22C11 (Millipore, Billerica, MA), MAB348sAPPa (Covance, Princeton, NJ,
Sig-39151), APP (Sigma-Aldrich, A8717), Cadherin 6 (Abcam/Epitomics, EPR217), Calnexin (Enzo,
Stressgen, Farmingdale, NY, USA, ADI-SPA-860), Calbindin, (rabbit polyclonal anti-calbindin D-28k
antibodies Swant, Bellinzona, Switzerland), mContactin (R&D Systems, Wiesbaden,
Germany, AF4439), DNER (R&D Systems, AF2254), GFAP (Sigma-Aldrich, G3893), L1CAM Clone
555 (kindly provided by Peter Altevogt), LDL receptor (R&D systems, AF2255), Lrrc4b (R&D systems,
AF4995), MT4-MMP (MMP17), (Abcam/Epitomics, EP1270Y), N-Cadherin (Abcam/Epitomics,
EPR1791-4), NrCAM (Abcam, ab24344), Neuroligin-1 (Synaptic Systems, Go¨ttingen, Germany 4C12),
Synaptophysin (mouse monoclonal Sigma-Aldrich). Biotin-SP-conjugated goat anti-mouse secondary
antibodies (Jackson Immunoresearch Laboratories, West Grove, Pa.), and Cy3-conjugated streptavi-
din (Dianova, Hamburg, Germany), Alexa 488 goat anti-rabbit secondary antibodies (Molecular
Probes, Leiden, The Netherlands).
ELISA
Levels of murine fractalkine (CX3CL1) were measured using an Elisa Kit (R&D systems, detection limit
98 pg/ml). Samples were stored at -80˚C and analyzed undiluted after thawing.
Mice
The generation and genotyping of knockout lines was formerly described: ADAM10 conditional KO
embryos (Gibb et al., 2010), ADAM10 conditional KO mouse crossed with CamkII-Cre (Prox et al.,
2013), APPsa-KI (Ring et al., 2007).
Generation of Adam10 cKO, sAPPa knockin mice
Homozygous Adam10 deficient sAPPa knockin (sAPPaki) mice were generated from Adam10F/F
CaMKIIa-Cretg/+ mice (Prox et al., 2013) crossed with APPsa-KI mice (Ring et al., 2007). Geno-
types were confirmed by specific PCR on tail biopsies. PCR on CaMKIIa-Cre and floxed Adam10 was
performed as previously described (Prox et al., 2013). PCR on sAPPa was performed with primers
5’GGCTGACAAACATCAAGACGGAAGAG3’, 5’CACACCTCCCCCTGAACCTGAAAC3’ and 5’CTG-
CGAGAGAGCATCCCTACAACC3’.
Primary culture
Embryonic primary cortical neurons were prepared as described (Kuhn et al., 2010; Colombo et al.,
2013). Briefly, cortex samples from ADAM10 conditional KO embryos (Gibb et al., 2010) were col-
lected and dissociated in DMEM plus 200 U of papain (Sigma Aldrich). Neurons were plated in 6
well plates precoated with poly-D-lysine (1.5106 cells/well). Plating medium was 10% (v/v) fetal calf
serum FCS/DMEM which was changed after 4 hr to B27/Neurobasal (Thermo, Braunschweig, Ger-
many) supplemented with 0.5 mM glutamine and 1% P/S. All experimental procedures on animals
were performed in accordance with the European Communities Council Directive (86/609/EEC).
Virus production
Codon-improved Cre recombinase (iCre) (Shimshek et al., 2002) expressing lentiviral particles were
generated as previously described (Kuhn et al., 2010; Colombo et al., 2013). Briefly, lentiviruses
were generated by transient cotransfection of HEK293T cells (DSMZ, Braunschweig, Germany) with
the plasmids psPAX2, pCDNA3.1( )-VSV-G and as transfer vector F2UDZeo-iCre using Lipofect-
amine 2000 (Thermo). Lentiviral particles for infection of murine primary cortical neurons were con-
centrated and purified by ultracentrifugation. Lentiviral stocks were stored at  80˚C until use.
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SPECS
Secretome enriched and subsequent proteomic analyses were essentially performed as described
earlier (Kuhn et al., 2012). In brief, 40 million neurons were plated. After two div, neurons were
infected with concentrated lentiviruses coding for iCre or Control. After five div neurobasal medium
was exchanged for neurobasal medium supplemented with 200 nM tetraacetyl-N-azidoacetyl man-
nosamine (ManNAZ). Two days conditioned media were subsequently collected and filtered through
0.45 mm PVDF Millex filter (Millipore, Darmstadt, Germany) into a VivaSpin 20 centrifugal concentra-
tor (30 kDa) at 4˚C. VivaSpin 20 columns were centrifuged at 4600 rpm at 4˚C to remove non-metab-
olized ManNAZ. The retentate was filled with 20 ml H2O. This procedure was repeated three times.
In the last step, the ddH2O refill step was omitted. Instead, 100 nM of DBCO-PEG12-biotin
(Click Chemistry Tools, Scottsdale, AZ) diluted in 1 ml ddH2O was added to biotinylate metabolically
azide-labelled glycoproteins. Centrifugal concentrators were incubated overnight at 4˚C. For
removal of non-reacted DBCO-PEG12-Biotin, VivaSpin20 centrifugal concentrators were subjected
to three times of centrifugation with subsequent ddH2O refill. After the last centrifugation step, the
retentate was diluted in 5 ml PBS with 2% SDS (v/v) and 2 mM Tris 2-carboxyethyl-phosphine
(TCEP). For purification of biotinylated proteins, the sample was loaded on a 10-ml polyprep column
with a streptavidin bead bed formed of 300 ml streptavidin slurry. After binding of proteins, strepta-
vidin beads were washed three times with 10 ml PBS supplemented with 1% SDS. To elute the bioti-
nylated and azide-labelled glycoproteins, streptavidin beads were boiled with urea sample buffer
containing 3 mM biotin to compete for the binding of biotinylated proteins.
SPECS-labeling of cellular glycoproteins
Neurons that were labeled with 200 nM ManNAz for 48 hr were washed twice with 5 ml cold PBS.
Afterwards 100 nM DBCO-PEG12-biotin (Click Chemistry Tools) diluted in 2 ml PBS were evenly dis-
tributed on the neurons and incubated at 4˚C for 2 hr. After the incubation period, neurons were
washed twice with 5 ml PBS to be lysed in 5 ml STE buffer (NaCl, 150 mM, Tris 50 mM, 2 mM EDTA)
with 1% (v/v) NP40 per flask. Lysates were subjected to a clarifying spin at 4000 g. The clarified
lysate was subsequently loaded on a polyprep column with a streptavidin bead bed formed of 300
ml streptavidin slurry. After binding of proteins, streptavidin beads were washed three times with 10
ml PBS supplemented with 1% SDS. To elute the biotinylated and azide-labelled glycoproteins,
streptavidin beads were boiled with urea sample buffer containing 3 mM biotin to compete for the
binding of biotinylated proteins.
Brain homogenates of conditional ADAM10 (AD10 fl/fl) CamkII-Cre
mice
Brain homogenates were prepared as previously described (Kuhn et al., 2012) from P20 brains of
conditional ADAM10 (AD10 fl/f) CamkII-Cre mice (Prox et al., 2013).
Brain homogenates of ADAM10 cKO, sAPPa knockin mice
Mice were sacrificed at postnatal day P20 and brain regions were prepared (cortex, hippocampus
and cerebellum). Samples were homogenized and lysed in cell lysis buffer (5 mM Tris base pH 7.4, 1
mM EGTA, 250 mM sucrose, 1% Triton X-100 supplied with protease inhibitors) by passing 15 times
through a 23 G syringe and incubated for 1 hr at 4˚C. Cell debris was pelleted and protein concen-
tration in the supernatant was determined by BCA assay (Pierce, Thermo Fisher Scientific, Waltham,
Ma). To analyze APP processing, samples were homogenized and lysed in RIPA buffer (50 mM
HEPES pH 7.4, 150 mM sodium chloride, 1 mM EDTA, 0.1% SDS, 1% NP-40, 0.5 mM sodium deoxy-
cholate supplied with protease inhibitors) by passing 15 times through a 23 G syringe. Cell debris
was pelleted and supernatant was centrifuged (1 hr, 120000 x g, 4˚C). Protein concentration in the
supernatant was determined by BCA assay (Pierce). Samples were separated in either a 10% SDS-
PAGE or a 4–12% gradient BIS/Tris NuPAGE Novex gels (Thermo Fisher Scientific) and transferred
to nitrocellulose membranes (Roth, Karlsruhe, Germany) to perform Western blot analysis.
Ultrastructural analysis of hippocampal sections
Ultrastructural sample preparation and analysis was performed as previously described (Prox et al.,
2013).
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SDS–PAGE separation, trypsinization
Proteins were separated on a 10% Tris/glycine SDS gel. Afterwards, qualitatively equal gel slices
were cut out from the gel with the exception of the remaining albumin band at around 60 kDa. Pro-
teins in the gel slices were subject to trypsinization according to standard protocols (Kuhn et al.,
2015).
Western blot validation of substrates
For Western blot analysis of conditioned media and cell lysates of ADAM10 knockout neurons 20 ml
of 48 hr conditioned supernatant (1.5 ml) of a six well plate with 1.5x106 neurons and 20 ml of 250 ml
cell lysate of a six well plate with 1.5x106 neurons were loaded onto Tris/glycine SDS gels respec-
tively. Proteins were transferred to 0,45 mm nitrocellulose membranes and blocked with skim milk
prior to decoration with primary and secondary antibody. Six biological replicates were analyzed for
each substrate.
Mass spectrometric analysis
Mass spectrometry experiments were performed on an Easy NLC 1000 nanoflow HPLC system II
(Proxeon, Odense, Denmark) connected to an LTQ-Velos Orbitrap Pro (Thermo Fisher Scientific,
Braunschweig, Germany). Peptides were separated by reverse phase chromatography using in-house
made 30 cm columns (New Objective, FS360-75-8-N-S-C30, Woburn, MA) packed with C18-AQ 2,4
mm resin (Dr Maisch GmbH, Ammerbuch-Entringen, Germany, Part No. r124.aq). A 90-min gradient
(5–40%) at a flow rate of 200 nl/min was used. The measurement method consisted of an initial
FTMS scan recorded in profile mode with 30000 m/z resolution, a mass range from 300 to 2000 m/z
and a target value of 1000000. Subsequently, collision-induced dissociation (CID) fragmentation was
performed for the 15 most intense ions with an isolation width of 2 Da in the ion trap. A target value
of 10000, enabled charge state screening, a monoisotopic precursor selection, 35% normalized colli-
sion energy, an activation time of 10 ms, wide band activation and a dynamic exclusion list with 30 s
exclusion time were applied.
Analysis of mass spectrometry data
Considering that every biological replicate had been analyzed twice with mass spectrometry (techni-
cal replicate) after sample processing, five biological replicates with 2 technical replicates each of
the neuronal secretome upon ADAM10 knockout and four biological replicates with two technical
replicates each of the neuronal ADAM10 knockout surface proteome were analyzed with the freely
available MaxQuant suite (version 1.4.1.2) (Suzuki et al., 2012). Protein identification was performed
using the integrated Andromeda search algorithm (Reiss et al., 2005). First search, mass recalibra-
tion and main search of tryptic peptides were performed using a murine Uniprot database down-
loaded on the 08/21/2014 (86749 entries) for the ADAM10 secretome dataset and a murine Uniprot
database downloaded on the 05/16/2014 (86749 entries) for the ADAM10 surfaceome dataset. Two
missed cleavages were allowed. Peptide as well as protein false discovery rate was set to 1%. Mass
accuracy was set to 20 ppm for the first search and 5 ppm for the main search. Quantification was
performed between the respective control and ADAM10 knockout conditions on the basis of unique
and razor peptides. Missing values were imputed in Perseus 1.5.16 following a standard distribution.
p-values were calculated from log2 transformed relative intensity ratios of 5 biological replicates for
the neuronal secretome and 4 biological replicates for the neuronal surface proteome with a hetero-
scedastic, two-sided student’s t-test. Proteins with a p-value of p0.05 were considered as hits. To
correct for multiple hypothesis testing the Benjamini-Hochberg post hoc was applied with an
adjusted false-discovery rate of 0.10. MaxQuant output files (protein groups and peptides) are
attached as Supplementary file 3 for the neuronal secretome and the neuronal surface proteome.
Calculated values on which the volcanos are based are attached as Supplementary file 1 for the
neuronal secretome and Supplementary file 2 for the neuronal surface proteome. The mass spec-
trometry secretome raw data including MaxQuant output files have been deposited at the Proteo-
meXchange Consortium (http://proteomecentral.proteomexchange.org) via the PRIDE partner
repository with the data set identifier PXD003426.
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Immunohistochemistry for synaptophysin
Animals were deeply anesthetized with chloral hydrate (7% in saline, intraperitoneally), and perfused
intracardially with PBS followed by 4% paraformaldehyde in PBS. The brains were post-fixed over-
night at 4˚C in the same fixative. Sections 60 mm thick were cut using a vibratome and collected in
PBS. The free floating sections were incubated 15 min in methanol/PBS 1:1 containing 1% H2O2 and
blocked 45 min in a 5% BSA solution in PBS. Sections were then incubated with primary antibodies
in PBS containing 0.25% BSA, 0.1% Triton X-100 and 0.05% NaN3 for two nights at 4˚C with gentle
shaking. For the detection of synaptophysin, sections were incubated 90 min with biotinylated sec-
ondary antibody diluted in PBS, washed three times, and incubated 45 min with CyTM3-conjugated
streptavidin. Then, sections were mounted on glass slides in PBS-glycerol 1:1 containing 0.1% Dapco
(1,4-diazabicyclo [2.2.2.] octane, Sigma-Aldrich), and analyzed using an oil-immersion (HCX APO
63X/1.40 NA) objective coupled to a TCS SP5 confocal microscope (Leica, Bensheim, Germany). An
experimenter not aware of the genotype of the mice was able to identify all mutants according to
the synaptophysin immunostaining detected in the CA3 subfield of the hippocampus (Montag-
Sallaz et al., 2002). For quantification of synaptophysin positve puncta, pictures of 164 x 164 mm
(512x512 px, 320nm pixel width and height) from the CA3 region were taken. The stratum pyrami-
dale was delineated with straight lines and analyzed with the counting particles option of ImageJ.
The average area of small synaptophysin reactive puncta (0.64817 mm2 SD of 0.57921) representing
inhibitory synapses was determined in wild-type mice and used to define the threshold for large
puncta (average size of small puncta + 2x SD). Above this threshold (1.80659 mm2) number and
size of large immunoreactive puncta, representing mossy fiber terminals, were determined for wild-
type and ADAM10-deficient mice.
Lectin staining
Animals were perfused as described for the immunocytochemistry of synaptophysin. The brains were
post-fixed 4 to 6 hr at 4˚C in the same fixative, cryoprotected overnight in a solution of 30% sucrose
in PBS, and frozen. Frontal olfactory bulb cryosections (60 mm thick) were collected in PBS. The free
floating sections were incubated 15 min in methanol/PBS 1:1 containing 1% H2O2, blocked with a
2% BSA solution in PBS for 30 min, and then incubated for 2 hr with the plant lectin DBA conjugated
to biotin (Dolichos Biflorus Agglutinin, Sigma) at 20 mg/ml in PBS and 0.25% Triton X-100. For the
detection of the lectin, sections incubated 45 min with CyTM3-conjugated streptavidin. After wash-
ing in PBS, sections were mounted on glass slides with antifade media (Vectashield, Vector
Labs, Burlingame, Ca) containing 4´,6-diamidino-2-phenylindole (DAPI; 1.5 mg/ml) and sealed. DAPI
was used for nuclear staining. An experimenter not aware of the genotype of the mice was able to
identify all mutants according to the lectin staining detecting aberrantly projecting axons in the
olfactory bulb (Montag-Sallaz et al., 2002). On sections of the olfactory bulb from three animals per
genotype, lectin-stained glomeruli (KO n = 110; WT n = 126) were classified as compact or diffuse.
In WT, 89.2 ± 0.99% of all glomeruli were compact and 10.8 ± 0.99% diffuse, whereas in KO only
58.2 ± 9.1% were compact and 41.8 ± 9.4% diffuse.
Statistics
P-values for Western blots and ELISA were calculated with log2 transformed relative values using a
heteroscedastic, two-sided t-test. Immunohistochemical data were subjected to Analysis of Variance
(ANOVA, factor genotype) and post hoc analysis (Scheffe’s or Fisher PLSD) considering p<0.05 as
significant.
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